Midodrine & Fludrocortisone for Pressor Weaning

Part of the ICU Emergencies Hub — browse every related guide in one place.

Updated July 2026  |  More ICU nursing guides →

Every ICU nurse knows the frustration of a patient who is otherwise ready to leave the unit but is stuck on a low-dose norepinephrine drip — awake, extubated, eating, but tethered to a pump and a central line for one small number on the map. Two oral drugs, midodrine and fludrocortisone, are increasingly used to bridge that last gap and get patients off IV vasopressors. Here's what nurses need to understand about both.

Midodrine: an oral alpha-1 agonist

Midodrine is a prodrug converted to its active form, desglymidodrine, which is a direct alpha-1 adrenergic agonist. Activating alpha-1 receptors on vascular smooth muscle causes arterial and venous vasoconstriction, which raises systemic vascular resistance and blood pressure — the same broad mechanism as phenylephrine, but in an oral tablet with a longer, gentler onset.

Its original FDA indication is symptomatic orthostatic hypotension, not ICU pressor weaning. Using it to accelerate IV vasopressor liberation is a common off-label practice. The evidence is mixed: some studies suggest it can shorten IV vasopressor duration and ICU length of stay, while a notable randomized trial (MIDAS) did not find a reduction in time on IV vasopressors. Practice varies by unit, and it's typically reserved for patients who are hemodynamically stable and simply lingering on a very low pressor dose.

Typical dosing and nursing points

• Common ICU weaning doses run around 10 mg by mouth every 8 hours, sometimes titrated higher per protocol.
• Onset is roughly 30–60 minutes; effect lasts a few hours, which is why it's dosed several times daily.
• The classic teaching for outpatients — do not lie flat after a dose — matters here too because of supine hypertension.

Fludrocortisone: a mineralocorticoid, not a direct pressor

Fludrocortisone is a synthetic mineralocorticoid. It doesn't constrict vessels directly; instead it acts on the kidney to increase sodium and water reabsorption, expanding intravascular volume, and it up-regulates vascular sensitivity to circulating catecholamines. The net effect is a higher, better-defended blood pressure — useful in patients whose hypotension is partly volume- or sensitivity-driven, and in relative adrenal insufficiency.

In critical care it shows up in two main places: as an adjunct in orthostatic hypotension/dysautonomia, and — paired with hydrocortisone — in the corticosteroid regimen studied for septic shock (the APROCCHSS trial used hydrocortisone plus fludrocortisone). It is dosed once daily (commonly 50 mcg), which makes it easy to miss on a busy med pass.

Midodrine vs fludrocortisone at a glance

How they fit into a weaning plan

The usual sequence is to first ensure the patient is truly resuscitated — not simply dry. Volume status, source control, and correcting reversible causes come before any oral agent. Once a patient is stable on a minimal IV vasopressor dose, midodrine may be started and the IV pressor titrated down as tolerated, watching the MAP and heart rate closely at each step. Fludrocortisone is more often used for its volume and sensitization effects, or as part of a steroid regimen, rather than as a rapid on/off tool. Neither is a substitute for adequate resuscitation, and both are held or reconsidered if the patient destabilizes.

Related: norepinephrine guide, phenylephrine guide, and hydrocortisone in septic shock.